Global Value & Evidence Team Lead Pneumococcal Vaccines
Pfizer Inc., Netherlands
Mark has over 15 years of experience in HEOR and Market Access from a government, industry, and academic perspective. He holds a PhD in Health Economics and successfully completed an eMBA. Experienced in multiple disease areas including oncology, cardiovascular, infectious disease, and rare diseases. Experience: • Leading the global HEOR strategy development and implementation to support brand strategies and product positioning • Formulating and overseeing the evidence generation and communication/publication activities • Real-world data (RWD) and RWE generation strategy and studies (including epidemiological and Registry studies) • Creating state of the art global Cost-Effectiveness and Budget Impact Models from scratch • Leading the development of Global Value and AMCP Dossiers • Developing Payer Tools • Innovative Contracting & Price Negotiation • (Global) Market Access & Pricing Strategies Published over 90 studies in the area of health economics, epidemiology, burden of disease, meta-analyses, and systematic reviews: